Top Ranked Momentum Stocks to Buy for October 25th

In this article:

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, October 25th:

Costamare Inc. (CMRE): This containership and liner owning and chartering company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.1% over the last 60 days.

Costamare Inc. Price and Consensus

Costamare Inc. Price and Consensus
Costamare Inc. Price and Consensus

Costamare Inc. price-consensus-chart | Costamare Inc. Quote

Costamare’s shares gained 13.1% over the last one month above the S&P 500’s increase 0.9%. The company possesses a Momentum Score of A.

Costamare Inc. Price

Costamare Inc. Price
Costamare Inc. Price

Costamare Inc. price | Costamare Inc. Quote

DHT Holdings, Inc. (DHT): This owner and operator crude oil tankers has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.

DHT Holdings, Inc. Price and Consensus

DHT Holdings, Inc. Price and Consensus
DHT Holdings, Inc. Price and Consensus

DHT Holdings, Inc. price-consensus-chart | DHT Holdings, Inc. Quote

DHT Holdings’ shares gained 22.6% over the last one month. The company possesses a Momentum Score of A.

DHT Holdings, Inc. Price

DHT Holdings, Inc. Price
DHT Holdings, Inc. Price

DHT Holdings, Inc. price | DHT Holdings, Inc. Quote

First American Financial Corporation (FAF): This financial services company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing nearly 2.8% over the last 60 days.

First American Financial Corporation Price and Consensus

First American Financial Corporation Price and Consensus
First American Financial Corporation Price and Consensus

First American Financial Corporation price-consensus-chart | First American Financial Corporation Quote

First American Financial’s shares gained 4.4% over the last one month. The company possesses a Momentum Score of A.

First American Financial Corporation Price

First American Financial Corporation Price
First American Financial Corporation Price

First American Financial Corporation price | First American Financial Corporation Quote

Vertex Pharmaceuticals Incorporated (VRTX): This developer of therapies for treating cystic fibrosis has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing nearly 2% over the last 60 days.

Vertex Pharmaceuticals Incorporated Price and Consensus

Vertex Pharmaceuticals Incorporated Price and Consensus
Vertex Pharmaceuticals Incorporated Price and Consensus

Vertex Pharmaceuticals Incorporated price-consensus-chart | Vertex Pharmaceuticals Incorporated Quote

Vertex Pharmaceuticals’ shares gained 13.4% over the last one month. The company possesses a Momentum Score of A.

Vertex Pharmaceuticals Incorporated Price

Vertex Pharmaceuticals Incorporated Price
Vertex Pharmaceuticals Incorporated Price

Vertex Pharmaceuticals Incorporated price | Vertex Pharmaceuticals Incorporated Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

5 Stocks Set to Double

Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.

Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.

Today, See These 5 Potential Home Runs >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Vertex Pharmaceuticals Incorporated (VRTX) : Free Stock Analysis Report
 
First American Financial Corporation (FAF) : Free Stock Analysis Report
 
DHT Holdings, Inc. (DHT) : Free Stock Analysis Report
 
Costamare Inc. (CMRE) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

Advertisement